Titre :
  • Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.
Auteur : Katlama, Christine ; Esposito, Roberto ; Gatell, Jose ; Goffard, Jean-Christophe ; Grinsztejn, Beatriz ; Pozniak, Anton ; Rockstroh, Jürgen ; Stoehr, Albrecht ; Vetter, Norbert ; Yeni, Patrick ; Parys, Wim ; Vangeneugden, Tony ; POWER 1 study group
Informations sur la publication : AIDS, 21, 4, (page 395-402)
Statut de publication : Publié, 2007-02
Sujet CREF : Médecine interne
Mots-clés : Darunavir
Efficacy
HIV
Protease inhibitor
Safety
TMC114
Treatment-experienced patients
Mots-clés MeSH : Adult
CD4 Lymphocyte Count
Double-Blind Method
Drug Therapy, Combination
Female
HIV Infections -- drug therapy -- immunology -- virology
HIV Protease Inhibitors -- adverse effects -- therapeutic use
HIV-1
Humans
Male
Middle Aged
Ritonavir -- adverse effects -- therapeutic use
Sulfonamides -- adverse effects -- therapeutic use
Treatment Outcome
Viral Load
Note : Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0269-9370 
info:doi/10.1097/QAD.0b013e328013d9d7
info:pii/00002030-200702190-00001
info:pmid/17301557